Correlation between gene expression and osteoarthritis progression in human

International Journal of Molecular Sciences

Volumn 17, Issue 7, 2016, Pages

  Zhong, Leilei ^a   Huang, Xiaobin ^a   Karperien, Marcel ^a   Post, Janine N ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Cartilage degeneration; Gene expression; Hypertrophy; OARSI grading; Osteoarthritis

Indexed keywords

AGGRECAN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 10 ALPHA1; DICKKOPF 1 PROTEIN; GREMLIN 1; PEPTIDES AND PROTEINS; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; WNT PROTEIN; BIOLOGICAL MARKER; MESSENGER RNA;

AGED; APOPTOSIS; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA ISOLATION; SCORING SYSTEM; TUNEL ASSAY; UPREGULATION; ARTICULAR CARTILAGE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; APOPTOSIS; BIOMARKERS; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; OSTEOARTHRITIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84978529229     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17071126     Document Type: Article

References (55)

1. Felson, D. T.; Zhang, Y.; Hannan, M. T.; Naimark, A.; Weissman, B. N.; Aliabadi, P.; Levy, D. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1995, 38, 1500-1505. [CrossRef] [PubMed].
2. Goldring, M. B.; Goldring, S. R. Osteoarthritis. J. Cell. Physiol. 2007, 213, 626-634. [CrossRef] [PubMed].
3. Altman, R. D.; Dean, D. D. Osteoarthritis research: Animal models. Semin. Arthritis Rheum. 1990, 19, 21-25. [CrossRef].
4. Bendele, A.; McComb, J.; Gould, T.; McAbee, T.; Sennello, G.; Chlipala, E.; Guy, M. Animal models of arthritis: Relevance to human disease. Toxicol. Pathol. 1999, 27, 134-142. [CrossRef] [PubMed].
5. Bendele, A. M. Animal models of osteoarthritis. J. Musculoskelet. Neuronal. Interact. 2001, 1, 363-376. [PubMed].
6. Ramos, Y. F.; den Hollander, W.; Bovee, J. V.; Bomer, N.; van der Breggen, R.; Lakenberg, N.; Keurentjes, J. C.; Goeman, J. J.; Slagboom, P. E.; Nelissen, R. G.; et al. Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study. PLoS ONE 2014, 9, e103056. [CrossRef] [PubMed].
7. Tardif, G.; Hum, D.; Pelletier, J. P.; Boileau, C.; Ranger, P.; Martel-Pelletier, J. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Semin. Arthritis Rheum. 2004, 50, 2521-2530. [CrossRef] [PubMed].
8. Kim, K. I.; Park, Y. S.; Im, G. I. Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage. J. Bone Miner. Res. 2013, 28, 1050-1060. [CrossRef] [PubMed].
9. Miosge, N.; Hartmann, M.; Maelicke, C.; Herken, R. Expression of collagen type I and type II in consecutive stages of human osteoarthritis. Histochem. Cell Biol. 2004, 122, 229-236. [CrossRef] [PubMed].
10. Leijten, J. C.; Emons, J.; Sticht, C.; van Gool, S.; Decker, E.; Uitterlinden, A.; Rappold, G.; Hofman, A.; Rivadeneira, F.; Scherjon, S.; et al. Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum. 2012, 64, 3302-3312. [CrossRef] [PubMed].
11. Leijten, J.; Georgi, N.; Moreira Teixeira, L.; van Blitterswijk, C. A.; Post, J. N.; Karperien, M. Metabolic programming of mesenchymal stromal cells by oxygen tension directs chondrogenic cell fate. Proc. Natl. Acad. Sci. USA 2014, 111, 13954-13959. [CrossRef] [PubMed].
12. Enomoto, H.; Enomoto-Iwamoto, M.; Iwamoto, M.; Nomura, S.; Himeno, M.; Kitamura, Y.; Kishimoto, T.; Komori, T. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J. Biol. Chem. 2000, 275, 8695-8702. [CrossRef] [PubMed].
13. Orfanidou, T.; Iliopoulos, D.; Malizos, K. N.; Tsezou, A. Involvement of SOX9 and FGF-23 in RUNX2 regulation in osteoarthritic chondrocytes. J. Cell. Mol. Med. 2009, 13, 3186-3194. [CrossRef] [PubMed].
14. Zheng, Q.; Zhou, G.; Morello, R.; Chen, Y.; Garcia-Rojas, X.; Lee, B. Type X collagen gene regulation by RUNX2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol. 2003, 162, 833-842. [CrossRef] [PubMed].
15. Von der Mark, K.; Frischholz, S.; Aigner, T.; Beier, F.; Belke, J.; Erdmann, S.; Burkhardt, H. Upregulation of type X collagen expression in osteoarthritic cartilage. Acta Orthop. Scand. Suppl. 1995, 266, 125-129. [PubMed].
16. Zhou, J.; Wei, X.; Wei, L. Indian hedgehog, a critical modulator in osteoarthritis, could be a potential therapeutic target for attenuating cartilage degeneration disease. Connect. Tissue Res. 2014, 55, 257-261. [CrossRef] [PubMed].
17. Wei, F.; Zhou, J.; Wei, X.; Zhang, J.; Fleming, B. C.; Terek, R.; Pei, M.; Chen, Q.; Liu, T.; Wei, L. Activation of Indian hedgehog promotes chondrocyte hypertrophy and upregulation of MMP-13 in human osteoarthritic cartilage. Osteoarthr. Cartil. 2012, 20, 755-763. [CrossRef] [PubMed].
18. Dell'Accio, F.; De Bari, C.; El Tawil, N. M.; Barone, F.; Mitsiadis, T. A.; O'Dowd, J.; Pitzalis, C. Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res. Ther. 2006, 8, R139. [CrossRef] [PubMed].
19. Pritzker, K. P.; Gay, S.; Jimenez, S. A.; Ostergaard, K.; Pelletier, J. P.; Revell, P. A.; Salter, D.; van den Berg, W. B. Osteoarthritis cartilage histopathology: Grading and staging. Osteoarthr. Cartil. 2006, 14, 13-29. [CrossRef] [PubMed].
20. Bi, W.; Deng, J. M.; Zhang, Z.; Behringer, R. R.; de Crombrugghe, B. SOX9 is required for cartilage formation. Nat. Genet. 1999, 22, 85-89. [PubMed].
21. Zhao, Q.; Eberspaecher, H.; Lefebvre, V.; de Crombrugghe, B. Parallel expression of SOX9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 1997, 209, 377-386. [CrossRef].
22. Leijten, J. C.; Bos, S. D.; Landman, E. B.; Georgi, N.; Jahr, H.; Meulenbelt, I.; Post, J. N.; van Blitterswijk, C. A.; Karperien, M. GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors. Arthritis Res. Ther. 2013, 15, R126. [CrossRef] [PubMed].
23. Mariani, E.; Pulsatelli, L.; Facchini, A. Signaling pathways in cartilage repair. Int. J. Mol. Sci. 2014, 15, 8667-8698. [CrossRef] [PubMed].
24. Almonte-Becerril, M.; Navarro-Garcia, F.; Gonzalez-Robles, A.; Vega-Lopez, M. A.; Lavalle, C.; Kouri, J. B. Cell death of chondrocytes is a combination between apoptosis and autophagy during the pathogenesis of Osteoarthritis within an experimental model. Apoptosis 2010, 15, 631-638. [CrossRef] [PubMed].
25. Pascual Garrido, C.; Hakimiyan, A. A.; Rappoport, L.; Oegema, T. R.; Wimmer, M. A.; Chubinskaya, S. Anti-apoptotic treatments prevent cartilage degradation after acute trauma to human ankle cartilage. Osteoarthr. Cartil. 2009, 17, 1244-1251. [CrossRef] [PubMed].
26. Buckwalter, J. A.; Saltzman, C.; Brown, T. The impact of osteoarthritis: Implications for research. Clin. Orthop. Relat. Res. 2004, 427, S6-S15. [CrossRef] [PubMed].
27. Brew, C. J.; Clegg, P. D.; Boot-Handford, R. P.; Andrew, J. G.; Hardingham, T. Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann. Rheum. Dis. 2010, 69, 234-240. [CrossRef] [PubMed].
28. Haag, J.; Gebhard, P. M.; Aigner, T. SOX gene expression in human osteoarthritic cartilage. Pathobiology 2008, 75, 195-199. [CrossRef] [PubMed].
29. Aigner, T.; Fundel, K.; Saas, J.; Gebhard, P. M.; Haag, J.; Weiss, T.; Zien, A.; Obermayr, F.; Zimmer, R.; Bartnik, E. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum. 2006, 54, 3533-3544. [CrossRef] [PubMed].
30. Aigner, T.; Gebhard, P. M.; Schmid, E.; Bau, B.; Harley, V.; Poschl, E. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol. 2003, 22, 363-372. [CrossRef].
31. Ma, B.; Leijten, J. C.; Wu, L.; Kip, M.; van Blitterswijk, C. A.; Post, J. N.; Karperien, M. Gene expression profiling of dedifferentiated human articular chondrocytes in monolayer culture. Osteoarthr. Cartil. 2013, 21, 599-603. [CrossRef] [PubMed].
32. Marlovits, S.; Hombauer, M.; Truppe, M.; Vecsei, V.; Schlegel, W. Changes in the ratio of type-I and type-II collagen expression during monolayer culture of human chondrocytes. J. Bone. Jt. Surg. Br. 2004, 86, 286-295. [CrossRef].
33. Casagrande, D.; Stains, J. P.; Murthi, A. M. Identification of shoulder osteoarthritis biomarkers: Comparison between shoulders with and without osteoarthritis. J. Shoulder Elbow Surg. 2015, 24, 382-390. [CrossRef] [PubMed].
34. Aigner, T.; Zien, A.; Gehrsitz, A.; Gebhard, P. M.; McKenna, L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum. 2001, 44, 2777-2789. [CrossRef].
35. Gebhard, P. M.; Gehrsitz, A.; Bau, B.; Soder, S.; Eger, W.; Aigner, T. Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes. J. Orthop. Res. 2003, 21, 96-101. [CrossRef].
36. Lane, N. E.; Nevitt, M. C.; Lui, L. Y.; de Leon, P.; Corr, M. Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum. 2007, 56, 3319-3325. [CrossRef] [PubMed].
37. Voorzanger-Rousselot, N.; Ben-Tabassi, N. C.; Garnero, P. Opposite relationships between circulating Dkk-1 and cartilage breakdown in patients with rheumatoid arthritis and knee osteoarthritis. Ann. Rheum. Dis. 2009, 68, 1513-1514. [CrossRef] [PubMed].
38. Honsawek, S.; Tanavalee, A.; Yuktanandana, P.; Ngarmukos, S.; Saetan, N.; Tantavisut, S. Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients. BMC Musculoskelet. Disord. 2010, 11. [CrossRef] [PubMed].
39. Lories, R. J.; Peeters, J.; Bakker, A.; Tylzanowski, P.; Derese, I.; Schrooten, J.; Thomas, J. T.; Luyten, F. P. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 2007, 56, 4095-4103. [CrossRef] [PubMed].
40. Huebner, J. L.; Johnson, K. A.; Kraus, V. B.; Terkeltaub, R. A. Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA. Osteoarthr. Cartil. 2009, 17, 1056-1064. [CrossRef] [PubMed].
41. Kim, D. Y.; Taylor, H. W.; Moore, R. M.; Paulsen, D. B.; Cho, D. Y. Articular chondrocyte apoptosis in equine osteoarthritis. Vet. J. 2003, 166, 52-57. [CrossRef].
42. Kamekura, S.; Kawasaki, Y.; Hoshi, K.; Shimoaka, T.; Chikuda, H.; Maruyama, Z.; Komori, T.; Sato, S.; Takeda, S.; Karsenty, G.; et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 2006, 54, 2462-2470. [CrossRef] [PubMed].
43. Van der Kraan, P. M.; van den Berg, W. B. Chondrocyte hypertrophy and osteoarthritis: Role in initiation and progression of cartilage degeneration? Osteoarthr. Cartil. 2012, 20, 223-232. [CrossRef] [PubMed].
44. Gouttenoire, J.; Valcourt, U.; Ronziere, M. C.; Aubert-Foucher, E.; Mallein-Gerin, F.; Herbage, D. Modulation of collagen synthesis in normal and osteoarthritic cartilage. Biorheology 2004, 41, 535-542. [PubMed].
45. Boos, N.; Nerlich, A. G.; Wiest, I.; von der Mark, K.; Ganz, R.; Aebi, M. Immunohistochemical analysis of type-X-collagen expression in osteoarthritis of the hip joint. J. Orthop. Res. 1999, 17, 495-502. [CrossRef] [PubMed].
46. Blom, A. B.; Brockbank, S. M.; van Lent, P. L.; van Beuningen, H. M.; Geurts, J.; Takahashi, N.; van der Kraan, P. M.; van de Loo, F. A.; Schreurs, B. W.; Clements, K.; et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: Prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 2009, 60, 501-512. [CrossRef] [PubMed].
47. Corr, M. Wnt-β-catenin signaling in the pathogenesis of osteoarthritis. Nat. Clin. Pract. Rheumatol. 2008, 4, 550-556. [CrossRef] [PubMed].
48. Shen, J.; Li, S.; Chen, D. TGF-β signaling and the development of osteoarthritis. Bone Res. 2014, 2. [CrossRef] [PubMed].
49. Papathanasiou, I.; Malizos, K. N.; Tsezou, A. Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes. Arthritis Res. Ther. 2012, 14. [CrossRef] [PubMed].
50. Blaney Davidson, E. N.; Vitters, E. L.; van der Kraan, P. M.; van den Berg, W. B. Expression of transforming growth factor-β (TGFβ) and the TGFβ signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: Role in cartilage degradation, chondrogenesis and osteophyte formation. Ann. Rheum. Dis. 2006, 65, 1414-1421. [CrossRef] [PubMed].
51. Nakase, T.; Miyaji, T.; Tomita, T.; Kaneko, M.; Kuriyama, K.; Myoui, A.; Sugamoto, K.; Ochi, T.; Yoshikawa, H. Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthr. Cartil. 2003, 11, 278-284. [CrossRef].
52. Schmal, H.; Salzmann, G. M.; Langenmair, E. R.; Henkelmann, R.; Sudkamp, N. P.; Niemeyer, P. Biochemical characterization of early osteoarthritis in the ankle. Sci. World J. 2014, 2014. [CrossRef] [PubMed].
53. Archer, C. W.; Francis-West, P. The chondrocyte. Int. J. Biochem. Cell Biol. 2003, 35, 401-404. [CrossRef].
54. Zamli, Z.; Sharif, M. Chondrocyte apoptosis: A cause or consequence of osteoarthritis? Int. J. Rheum. Dis. 2011, 14, 159-166. [CrossRef] [PubMed].
55. Landman, E. B.; Miclea, R. L.; van Blitterswijk, C. A.; Karperien, M. Small molecule inhibitors of WNT/β-catenin signaling block IL-1β-and TNFβ-induced cartilage degradation. Arthritis Res. Ther. 2013, 15, R93. [CrossRef] [PubMed].